CardioSM (Twitter) - ユーザ詳細

ShingoMatsumoto (@CardioSM)

投稿
お気に入り
フォロー
フォロワー

投稿一覧（最新100件）

15 0 0 0 OA New Vision, Mission, and Values of the Japanese Circulation Society

RT @JCIRC_IPR: 日本循環器学会の理念を世界に発信します。この理念を柱に、今後の活動を進めていきます。よろしくお願いします。 ✅New Vision, Mission, and Values of the Japanese Circulation Soci…

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

RT @tkishi_cardiol: 日本循環器学会 @JCIRC_IPR #COVID19 対策特命チームサブリーダーとして関わった研究です。 #circ_j Association Between Statin Use Prior to Admission and L…

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

RT @Office_j: 【日本人COVID-19にもスタチンは保護的？/ Circ J】 CLAVIS-COVIDレジストリ、CV高リスクCOVID-19入院1518例解析：入院時スタチン処方例 [31%]は併存症が多いにもかかわらず、ECMO装着率は1.4% [vs.…

29 0 0 0 OA Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors

日循COVID-19レジストリの結果がOnline publishされました。循環器疾患及びリスク因子合併COVID-19患者を対象に、年齢毎の特徴を解析しまとめています。日本も第4波に突入していますが、国内における「確かな情報」のひとつとして沢山の方に知って頂ければ幸いです。 ⬇️ https://t.co/q2HuJ05Ec0 https://t.co/mVhcitSJyn

9 0 0 0 OA Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic ― A Nationwide Survey in Japan by the Japanese Circulation Society―

RT @atmizu: COVID-19の昨年のアンケート第1弾の方です https://t.co/8UStK6PrvS 感謝でございます！よろしければチェックしていただけたら。 @JCIRC_IPR #CardioJapan https://t.co/j38591wvPn

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

RT @tkishi_cardiol: 日本循環器学会 @JCIRC_IPR #COVID19 対策特命チームを中心に、全国の先生方のご協力で完成したアンケート研究論文です！@atmizu 先生が見事にまとめてくれて、チーム全員で色々討論しました。引き続きどんどん出します。…

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

RT @atmizu: 日本循環器学会で実施した2回目のアンケートのまとめはこちらです！！ https://t.co/V6TeZZFVFA 緊急事態宣言で大変だと思いますが、さらに、通常の心疾患に関してもなんとか質を高く管理してやってゆきたいですよね！アンケート回答…

お気に入り一覧（最新100件）

13 0 0 0 OA Cardiovascular Hospitalizations and Hospitalization Costs in Japan During the COVID-19 Pandemic

日本のCOVID-19パンデミックにおいて、2020年に循環器入院患者が10%以上減少し、カテーテルアブレーションと弁膜症が年間入院費用減少の約半数を占めました。入院中の死亡率に変化はありませんでした。 By 杉本　匡史 @tadafumisugimo1 https://t.co/llHcZwr9g9 #circ_rep #CardioTwitter https://t.co/zcG9h82grz

2 0 0 0 OA 循環器内科医・心臓外科医の海外留学の実際第20 回

こちら2年前に雑誌心臓に寄稿した留学にまつわる文章です。今はフリーで読めるようです。フェローが始まって2年経ちましたがあくまで’挑戦'は続きます。7月など今年から留学が始まる方、お身体に気をつけて！留学はあくまでゴールではなく目的を達成するためのスタートです https://t.co/ccHvJ5obOu https://t.co/B77OjkfbG9

14 0 0 0 OA Visualization of relative measures of association: points and error bars with an appropriate axis scale

相対リスクの点推定値の可視化に関するレターがJournal of Epidemiologyに掲載されました

8 0 0 0 OA Editorial Statistics and Best Reviewers Award for 2021

I am very honored to be recognized as the Best Reviewers Awards for 2021 by Circulation Journal. #circ_j @JCIRC_IPR https://t.co/hpLv4zh0rb

15 0 0 0 OA New Vision, Mission, and Values of the Japanese Circulation Society

日本循環器学会の理念を世界に発信します。この理念を柱に、今後の活動を進めていきます。よろしくお願いします。 ✅New Vision, Mission, and Values of the Japanese Circulation Society by 情報広報部会長 https://t.co/NqY6IRCsbv

9 0 0 0 OA Impact of Atrial Fibrillation on the Prognosis of Acute Decompensated Heart Failure With and Without Mitral Regurgitation

心房細動は心不全の予後を悪化させたが、それは僧帽弁逆流例のみ。僧帽弁逆流のない心不全ではそうではなかった。 Impact of Atrial Fibrillation on the Prognosis of Acute Decompensated Heart Failure With and Without Mitral Regurgitation https://t.co/o3hOng2sWc

29 0 0 0 OA Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors

CLAVIS-COVID COVID-19 registry of #JCS Elderly patients with COVID-19 had high mortality (approximately 30%), regardless of the presence of CVD and/or CV risk factors. By Shingo Matsumoto @CircSM https://t.co/Kv0cYq7G4g #circ_j https://t.co/GXFlMXAcaw

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

日本循環器学会 @JCIRC_IPR #COVID19 対策特命チームサブリーダーとして関わった研究です。 #circ_j Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors https://t.co/Jn3MNcGN0O

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

【日本人COVID-19にもスタチンは保護的？/ Circ J】 CLAVIS-COVIDレジストリ、CV高リスクCOVID-19入院1518例解析：入院時スタチン処方例 [31%]は併存症が多いにもかかわらず、ECMO装着率は1.4% [vs. 4.6%：非服用]。敗血症性ショックも1.4% vs. 6.5% [いずれも有意差]。 https://t.co/dBWorsggLK

29 0 0 0 OA Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors

J-STAGE Articles - Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors https://t.co/BdEH6UxUcJ

9 0 0 0 OA Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic ― A Nationwide Survey in Japan by the Japanese Circulation Society―

COVID-19の昨年のアンケート第1弾の方です https://t.co/8UStK6PrvS 感謝でございます！よろしければチェックしていただけたら。 @JCIRC_IPR #CardioJapan https://t.co/j38591wvPn

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

日本循環器学会 @JCIRC_IPR #COVID19 対策特命チームを中心に、全国の先生方のご協力で完成したアンケート研究論文です！@atmizu 先生が見事にまとめてくれて、チーム全員で色々討論しました。引き続きどんどん出します。 #circ_rep https://t.co/MWrlltTCBv

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

日本循環器学会で実施した2回目のアンケートのまとめはこちらです！！ https://t.co/V6TeZZFVFA 緊急事態宣言で大変だと思いますが、さらに、通常の心疾患に関してもなんとか質を高く管理してやってゆきたいですよね！アンケート回答いただきました先生方ありがとうございました！！！

ShingoMatsumoto (@CardioSM)

投稿一覧（最新100件）

15 0 0 0 OA New Vision, Mission, and Values of the Japanese Circulation Society

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

29 0 0 0 OA Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors

9 0 0 0 OA Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic ― A Nationwide Survey in Japan by the Japanese Circulation Society―

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

お気に入り一覧（最新100件）

13 0 0 0 OA Cardiovascular Hospitalizations and Hospitalization Costs in Japan During the COVID-19 Pandemic

2 0 0 0 OA 循環器内科医・心臓外科医の海外留学の実際第20 回

14 0 0 0 OA Visualization of relative measures of association: points and error bars with an appropriate axis scale

8 0 0 0 OA Editorial Statistics and Best Reviewers Award for 2021

15 0 0 0 OA New Vision, Mission, and Values of the Japanese Circulation Society

9 0 0 0 OA Impact of Atrial Fibrillation on the Prognosis of Acute Decompensated Heart Failure With and Without Mitral Regurgitation

29 0 0 0 OA Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

29 0 0 0 OA Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors

9 0 0 0 OA Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic ― A Nationwide Survey in Japan by the Japanese Circulation Society―

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

フォロー（265ユーザ）の投稿一覧（直近7日間）

フォロワー（1611ユーザ）の投稿一覧（直近7日間）

ShingoMatsumoto (@CardioSM)

投稿一覧（最新100件）

15 0 0 0 OA New Vision, Mission, and Values of the Japanese Circulation Society

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

29 0 0 0 OA Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors

9 0 0 0 OA Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic ― A Nationwide Survey in Japan by the Japanese Circulation Society―

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

お気に入り一覧（最新100件）

13 0 0 0 OA Cardiovascular Hospitalizations and Hospitalization Costs in Japan During the COVID-19 Pandemic

2 0 0 0 OA 循環器内科医・心臓外科医の海外留学の実際 第20 回

14 0 0 0 OA Visualization of relative measures of association: points and error bars with an appropriate axis scale

8 0 0 0 OA Editorial Statistics and Best Reviewers Award for 2021

15 0 0 0 OA New Vision, Mission, and Values of the Japanese Circulation Society

9 0 0 0 OA Impact of Atrial Fibrillation on the Prognosis of Acute Decompensated Heart Failure With and Without Mitral Regurgitation

29 0 0 0 OA Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

7 0 0 0 OA Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

29 0 0 0 OA Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors

9 0 0 0 OA Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic ― A Nationwide Survey in Japan by the Japanese Circulation Society―

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

9 0 0 0 OA Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―

フォロー（265ユーザ）の投稿一覧（直近7日間）

フォロワー（1611ユーザ）の投稿一覧（直近7日間）

2 0 0 0 OA 循環器内科医・心臓外科医の海外留学の実際第20 回